Related Experiment Video
Updated: Jul 16, 2026
08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
Antibody-dependent cellular cytotoxicity in asthmatics.
The Journal of Allergy and Clinical Immunology
|January 1, 1977
Summary
Infectious asthma patients show reduced antibody-dependent cellular cytotoxicity (ADCC) in mononuclear cells compared to non-infectious asthmatics and healthy individuals. This immune dysfunction may be linked to asthma severity or treatment.
Area of Science:
- Immunology
- Respiratory Medicine
- Cellular Biology
Background:
- Asthma is a chronic respiratory disease characterized by airway inflammation.
- Immune system dysregulation is implicated in asthma pathogenesis.
- Antibody-dependent cellular cytotoxicity (ADCC) is a key immune mechanism involving cytotoxic cells.
Purpose of the Study:
- To investigate the antibody-dependent cellular cytotoxicity (ADCC) capacity in patients with infectious asthma.
- To compare ADCC levels in infectious asthmatics, non-infectious asthmatics, and normal controls.
- To explore potential correlations between ADCC function and disease characteristics.
Main Methods:
- Utilized a chromium-51 (51Cr)-labeled, antibody-coated chicken red blood cell assay.
- Prepared and tested mononuclear cells and granulocytes from three groups: infectious asthmatics, non-infectious asthmatics, and normal controls.
- Quantified ADCC capacity using corrected cytotoxic indices.
Main Results:
- Mononuclear cells from infectious asthmatics exhibited significantly reduced ADCC capacity (34 +/- 10 SD) compared to non-infectious asthmatics (47 +/- 7 SD) and normal controls (47 +/- 6 SD).
- Granulocyte preparations from infectious asthmatics and normal controls showed no significant difference in ADCC capacity.
- The study did not find a direct correlation between ADCC capacity and disease severity or in vivo drug treatment in the tested groups.
Conclusions:
- Infectious asthma is associated with impaired mononuclear cell-mediated ADCC.
- Reduced ADCC may represent a specific immune defect in infectious asthma.
- Further research is warranted to elucidate the role of ADCC in asthma pathophysiology and its potential as a therapeutic target.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...